Regeneron and Sanofi land the big one, winning FDA approval for their megablockbuster hopeful Dupixent
The FDA has approved the new eczema drug dupilumab from Regeneron and Sanofi, officially launching a new drug that is likely on course to creating …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
